Invenra Inc. is pleased to announce that its innovative bispecific antibody, INV724, developed for the treatment of neuroblastoma, has been awarded both Rare Pediatric...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Cayman Chemical, a leading supplier of high-quality lipids and tools for lipid nanoparticle (LNP) research and development, and Certest Pharma, a biotechnology company focused on...
ReAlta Life Sciences, Inc, a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases,...
Atossa Therapeutics, Inc and Quantum Leap Healthcare Collaborative, announced the first patient has been dosed in their clinical trial evaluating Atossa’s proprietary (Z)-endoxifen in...
